Advertisement
open access
Medical Conferences

Medical Conferences

  • Conference Reports
    • 2023 Medicom Conference Planning
  • Conference Proceedings
  • Disease Areas
  • Other Medical News
  • Media
    • Podcast
    • Video
    • Education
  • About
    • Conference Proceedings
    • Vacancies

Tag: Sacubitril

Sacubitril/valsartan reduces natriuretic peptides in HF patients with ejection fraction >40%

Presented By
Prof. Robert Mentz, Duke University Medical Center, NC, USA
Conference
HFA 2023

8 August, 2023 15:39

No effect of neprilysin inhibition on cognition

Presented By
Prof. John McMurray, University of Glasgow, UK
Trial
Phase 3, PERSPECTIVE
Conference
ESC 2022

27 October, 2022 14:41

ESC 2022 Highlights Podcast

Presented By
Dr Robert van den Heuvel, Medicom
Conference
ESC 2022

15 September, 2022 10:39

Therapeutic approaches in heart failure with diabetes

Presented By
Prof. Lynne Stevenson, Vanderbilt University Medical Center, USA
Conference
AHA 2021

14 January, 2022 14:48

2021 ESC Guidelines on Heart Failure

Presented By
Prof. Carolyn Lam, Duke-NUS Medical School, Singapore
Conference
ESC 2021

26 October, 2021 12:34

Real-world study suggests sacubitril/valsartan benefits elderly patients with HF

Presented By
Dr Andrea Herbst, Azienda Ospedaliero-Universitaria Careggi, Italy
Trial
PARADIGM-HF
Conference
HFA 2021

19 August, 2021 12:59

PARADISE-MI: Sacubitril/valsartan not superior to ramipril in reducing HF events

Presented By
Prof. Marc Pfeffer, Brigham and Women’s Hospital, USA
Trial
Phase 3, PARADISE-MI
Conference
ACC 2021

9 July, 2021 23:29

Sacubitril/valsartan does not reduce NT-proBNP versus valsartan alone in HFrEF

Presented By
Prof. Douglas Mann, Washington School of Medicine, USA
Trial
Phase 4, LIFE
Conference
ACC 2021

9 July, 2021 19:02

Reduced NT-proBNP in HFpEF with sacubitril/valsartan

Presented By
Prof. Burkert Pieske, Charité University Medicine Berlin, Germany
Trial
Phase 3, PARALLAX study
Conference
ESC 2020

5 November, 2020 13:26

PARAGON-HF: Benefits for women and lower ejection fraction

Expert
Prof. Scott D. Solomon & Prof. Lynne W. Stevenson
Trial
PARAGON-HF
Conference
AHA 2019

26 February, 2020 15:19

BNP still a reliable prognostic marker before and during sacubitril/valsartan treatment

Trial
PARADIGM-HF
Conference
ACC 2019

6 June, 2019 12:10
site created by:   

© 2023 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy